Cancer hiding in plain sight: benign biopsies may reveal early warning signs
Researchers have created a clinical dataset of prostate biopsies that initially appeared cancer-free but later developed tumors, offering a rare window into how the disease emerges. The work could help doctors identify high-risk patients earlier and reduce both unnecessary treatments and missed cancers—a major challenge costing healthcare systems billions annually.
Originaltitel: A clinical prostate biopsy dataset with undetected cancer
<p>Prostate cancer is a heterogeneous disease showing variability both among individuals and within a patient. While most cases are indolent, aggressive tumors require early intervention. Accurately predicting tumor behavior is challenging, contributing to overdiagnosis but also undertreatment. Current imaging methods may miss the most malignant areas, leading to biopsies often capturing non-malignant prostate tissue even if cancer is present elsewhere in the organ. This non-malignant tissue, however, holds potential as a source for novel diagnostic and prognostic markers. Our clinical dataset comprises men with raised prostate-specific antigen but whose initial prostate needle biopsies only contained benign tissue. Half of the paired patients remained cancer-free for over eight years, while the others were diagnosed with prostate cancer within 30 months of follow-up. We share these initial benign biopsies to enable the exploration of morphological changes in non-malignant tissue and the potential for improved diagnostic accuracy in the early identification of patients with prostate cancer.</p>